of cadre of mid-level
service providers, nurse
practitioners, public
health cadre to improve
availability of appropriate
health human resource.
It also seeks to address
health security and make
in India for drugs and
devices besides aligning
other policies for medical
devices and equipment
with public health goals.
The latest policy on
healthcare surely does
reflect the intent to take
into consideration all
the bottle necks. But
what will matter at the
end of the day is how
much translates into
action. Also, there are
still few decisions such as
universal health coverage,
rural health improvement,
regulations etc that will
need goal setting and
dedicated task forces
for implementation.
The National
Health Policy
2017 envisages
raising public
health expenditure
progressively
to 2.5% of the
GDP by 2025.
Some key targets
that the policy
seeks to achieve:
Life Expectancy
and healthy life
• Increase Life
Expectancy at birth
from 67.5 to 70 by
2025.
• Establish regular
tracking of Disability
Adjusted Life Years
(DALY) Index as a
measure of burden of
disease and its trends
by major categories by
2022.
• Reduction of TFR to 2.1
at national and sub-
national level by 2025.
Mortality by
age or cause
• R
educe Under Five
Mortality to 23 by 2025
and MMR from current
levels to 100 by 2020.
• Reduce infant mortality
rate to 28 by 2019.
• Reduce neo-natal
mortality to 16 and still
birth rate to “single
digit” by 2025.
• Reduction of disease
prevalence/ incidence
• Achieve global target
of 2020 which is also
termed as target of
90:90:90, for HIV/
AIDS i. e,- 90% of
all people living with
•
•
•
•
HIV know their HIV
status, - 90% of all
people diagnosed
with HIV infection
receive sustained
antiretroviral therapy
and 90% of all people
receiving antiretroviral
therapy will have viral
suppression.
Achieve and maintain
elimination status
of Leprosy by 2018,
Kala-Azar by 2017 and
Lymphatic Filariasis
in endemic pockets by
2017.
To achieve and
maintain a cure rate of
>85% in new sputum
positive patients for TB
and reduce incidence
of new cases, to reach
elimination status by
2025.
To reduce the
prevalence of blindness
to 0.25/ 1000 by 2025
and disease burden by
one third from current
levels.
To reduce premature
mortality from
cardiovascular diseases,
cancer, diabetes or
chronic respiratory
diseases by 25% by
2025.
BIOVOICENEWS.COM
55